Opinion
FDA chief Marty Makary says 'everything should be over the counter' unless drug is unsafe or addictive
Makary said the FDA is looking at prescription drugs like nausea medications and vaginal estrogen, and hopes to make changes this year.
KSL
FDA will drop 2-study requirement for new drug approvals, aiming to speed access
WASHINGTON — The Food and Drug Administration plans to drop its longtime standard of requiring two rigorous studies to win approval for new drugs, the latest change from Trump administration officials ...